Report Detail
Global Mitral Regurgitation Market Growth (Status and Outlook) 2022-2028
- RnM4398787 |
- 15 March, 2022 |
- Global |
- 120 Pages |
- LPI(LP Information) |
- Medical Industry
As the global economy mends, the 2021 growth of Mitral Regurgitation will have significant change from previous year. According to our (LP Information) latest study, the global Mitral Regurgitation market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Mitral Regurgitation market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Mitral Regurgitation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mitral Regurgitation market, reaching US$ million by the year 2028. As for the Europe Mitral Regurgitation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Mitral Regurgitation players cover Edwards Lifesciences, Abbott, CardioSolution, and NeoChord, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mitral Regurgitation market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Primary Mitral Regurgitation
Secondary Mitral Regurgitation
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Transapical
Via Stock and Via Interstitial
Right Internal Jugular Vein
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Edwards Lifesciences
Abbott
CardioSolution
NeoChord
Mitralign
Medtronic
Boston Scientific
Mitralix
Shanghai Hanyu Medical Technology
Valgen Holding Corporation
NeoChord
CoreMedic
Babic Chord
Gore Medical
Valtech Cardio
Transcardiac
ChoRe
AVVIE
Cardiovalve
HighLife SAS
Neovasc
MitrAssist Lifesciences
Shanghai NewMed Medical
Peijia Medical
MicroPort CardioFlow Medtech
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Mitral Regurgitation Market Size 2017-2028
- 2.1.2 Mitral Regurgitation Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Mitral Regurgitation Segment by Type
- 2.2.1 Primary Mitral Regurgitation
- 2.2.2 Secondary Mitral Regurgitation
- 2.3 Mitral Regurgitation Market Size by Type
- 2.3.1 Mitral Regurgitation Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Mitral Regurgitation Market Size Market Share by Type (2017-2022)
- 2.4 Mitral Regurgitation Segment by Application
- 2.4.1 Transapical
- 2.4.2 Via Stock and Via Interstitial
- 2.4.3 Right Internal Jugular Vein
- 2.5 Mitral Regurgitation Market Size by Application
- 2.5.1 Mitral Regurgitation Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Mitral Regurgitation Market Size Market Share by Application (2017-2022)
3 Mitral Regurgitation Market Size by Player
- 3.1 Mitral Regurgitation Market Size Market Share by Players
- 3.1.1 Global Mitral Regurgitation Revenue by Players (2020-2022)
- 3.1.2 Global Mitral Regurgitation Revenue Market Share by Players (2020-2022)
- 3.2 Global Mitral Regurgitation Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Mitral Regurgitation by Regions
- 4.1 Mitral Regurgitation Market Size by Regions (2017-2022)
- 4.2 Americas Mitral Regurgitation Market Size Growth (2017-2022)
- 4.3 APAC Mitral Regurgitation Market Size Growth (2017-2022)
- 4.4 Europe Mitral Regurgitation Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Mitral Regurgitation Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Mitral Regurgitation Market Size by Country (2017-2022)
- 5.2 Americas Mitral Regurgitation Market Size by Type (2017-2022)
- 5.3 Americas Mitral Regurgitation Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Mitral Regurgitation Market Size by Region (2017-2022)
- 6.2 APAC Mitral Regurgitation Market Size by Type (2017-2022)
- 6.3 APAC Mitral Regurgitation Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Mitral Regurgitation by Country (2017-2022)
- 7.2 Europe Mitral Regurgitation Market Size by Type (2017-2022)
- 7.3 Europe Mitral Regurgitation Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Mitral Regurgitation by Region (2017-2022)
- 8.2 Middle East & Africa Mitral Regurgitation Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Mitral Regurgitation Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Mitral Regurgitation Market Forecast
- 10.1 Global Mitral Regurgitation Forecast by Regions (2023-2028)
- 10.1.1 Global Mitral Regurgitation Forecast by Regions (2023-2028)
- 10.1.2 Americas Mitral Regurgitation Forecast
- 10.1.3 APAC Mitral Regurgitation Forecast
- 10.1.4 Europe Mitral Regurgitation Forecast
- 10.1.5 Middle East & Africa Mitral Regurgitation Forecast
- 10.2 Americas Mitral Regurgitation Forecast by Country (2023-2028)
- 10.2.1 United States Mitral Regurgitation Market Forecast
- 10.2.2 Canada Mitral Regurgitation Market Forecast
- 10.2.3 Mexico Mitral Regurgitation Market Forecast
- 10.2.4 Brazil Mitral Regurgitation Market Forecast
- 10.3 APAC Mitral Regurgitation Forecast by Region (2023-2028)
- 10.3.1 China Mitral Regurgitation Market Forecast
- 10.3.2 Japan Mitral Regurgitation Market Forecast
- 10.3.3 Korea Mitral Regurgitation Market Forecast
- 10.3.4 Southeast Asia Mitral Regurgitation Market Forecast
- 10.3.5 India Mitral Regurgitation Market Forecast
- 10.3.6 Australia Mitral Regurgitation Market Forecast
- 10.4 Europe Mitral Regurgitation Forecast by Country (2023-2028)
- 10.4.1 Germany Mitral Regurgitation Market Forecast
- 10.4.2 France Mitral Regurgitation Market Forecast
- 10.4.3 UK Mitral Regurgitation Market Forecast
- 10.4.4 Italy Mitral Regurgitation Market Forecast
- 10.4.5 Russia Mitral Regurgitation Market Forecast
- 10.5 Middle East & Africa Mitral Regurgitation Forecast by Region (2023-2028)
- 10.5.1 Egypt Mitral Regurgitation Market Forecast
- 10.5.2 South Africa Mitral Regurgitation Market Forecast
- 10.5.3 Israel Mitral Regurgitation Market Forecast
- 10.5.4 Turkey Mitral Regurgitation Market Forecast
- 10.5.5 GCC Countries Mitral Regurgitation Market Forecast
- 10.6 Global Mitral Regurgitation Forecast by Type (2023-2028)
- 10.7 Global Mitral Regurgitation Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Edwards Lifesciences
- 11.1.1 Edwards Lifesciences Company Information
- 11.1.2 Edwards Lifesciences Mitral Regurgitation Product Offered
- 11.1.3 Edwards Lifesciences Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Edwards Lifesciences Main Business Overview
- 11.1.5 Edwards Lifesciences Latest Developments
- 11.2 Abbott
- 11.2.1 Abbott Company Information
- 11.2.2 Abbott Mitral Regurgitation Product Offered
- 11.2.3 Abbott Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Abbott Main Business Overview
- 11.2.5 Abbott Latest Developments
- 11.3 CardioSolution
- 11.3.1 CardioSolution Company Information
- 11.3.2 CardioSolution Mitral Regurgitation Product Offered
- 11.3.3 CardioSolution Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 CardioSolution Main Business Overview
- 11.3.5 CardioSolution Latest Developments
- 11.4 NeoChord
- 11.4.1 NeoChord Company Information
- 11.4.2 NeoChord Mitral Regurgitation Product Offered
- 11.4.3 NeoChord Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 NeoChord Main Business Overview
- 11.4.5 NeoChord Latest Developments
- 11.5 Mitralign
- 11.5.1 Mitralign Company Information
- 11.5.2 Mitralign Mitral Regurgitation Product Offered
- 11.5.3 Mitralign Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Mitralign Main Business Overview
- 11.5.5 Mitralign Latest Developments
- 11.6 Medtronic
- 11.6.1 Medtronic Company Information
- 11.6.2 Medtronic Mitral Regurgitation Product Offered
- 11.6.3 Medtronic Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Medtronic Main Business Overview
- 11.6.5 Medtronic Latest Developments
- 11.7 Boston Scientific
- 11.7.1 Boston Scientific Company Information
- 11.7.2 Boston Scientific Mitral Regurgitation Product Offered
- 11.7.3 Boston Scientific Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Boston Scientific Main Business Overview
- 11.7.5 Boston Scientific Latest Developments
- 11.8 Mitralix
- 11.8.1 Mitralix Company Information
- 11.8.2 Mitralix Mitral Regurgitation Product Offered
- 11.8.3 Mitralix Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Mitralix Main Business Overview
- 11.8.5 Mitralix Latest Developments
- 11.9 Shanghai Hanyu Medical Technology
- 11.9.1 Shanghai Hanyu Medical Technology Company Information
- 11.9.2 Shanghai Hanyu Medical Technology Mitral Regurgitation Product Offered
- 11.9.3 Shanghai Hanyu Medical Technology Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Shanghai Hanyu Medical Technology Main Business Overview
- 11.9.5 Shanghai Hanyu Medical Technology Latest Developments
- 11.10 Valgen Holding Corporation
- 11.10.1 Valgen Holding Corporation Company Information
- 11.10.2 Valgen Holding Corporation Mitral Regurgitation Product Offered
- 11.10.3 Valgen Holding Corporation Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Valgen Holding Corporation Main Business Overview
- 11.10.5 Valgen Holding Corporation Latest Developments
- 11.11 NeoChord
- 11.11.1 NeoChord Company Information
- 11.11.2 NeoChord Mitral Regurgitation Product Offered
- 11.11.3 NeoChord Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 NeoChord Main Business Overview
- 11.11.5 NeoChord Latest Developments
- 11.12 CoreMedic
- 11.12.1 CoreMedic Company Information
- 11.12.2 CoreMedic Mitral Regurgitation Product Offered
- 11.12.3 CoreMedic Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 CoreMedic Main Business Overview
- 11.12.5 CoreMedic Latest Developments
- 11.13 Babic Chord
- 11.13.1 Babic Chord Company Information
- 11.13.2 Babic Chord Mitral Regurgitation Product Offered
- 11.13.3 Babic Chord Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Babic Chord Main Business Overview
- 11.13.5 Babic Chord Latest Developments
- 11.14 Gore Medical
- 11.14.1 Gore Medical Company Information
- 11.14.2 Gore Medical Mitral Regurgitation Product Offered
- 11.14.3 Gore Medical Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Gore Medical Main Business Overview
- 11.14.5 Gore Medical Latest Developments
- 11.15 Valtech Cardio
- 11.15.1 Valtech Cardio Company Information
- 11.15.2 Valtech Cardio Mitral Regurgitation Product Offered
- 11.15.3 Valtech Cardio Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Valtech Cardio Main Business Overview
- 11.15.5 Valtech Cardio Latest Developments
- 11.16 Transcardiac
- 11.16.1 Transcardiac Company Information
- 11.16.2 Transcardiac Mitral Regurgitation Product Offered
- 11.16.3 Transcardiac Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Transcardiac Main Business Overview
- 11.16.5 Transcardiac Latest Developments
- 11.17 ChoRe
- 11.17.1 ChoRe Company Information
- 11.17.2 ChoRe Mitral Regurgitation Product Offered
- 11.17.3 ChoRe Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 ChoRe Main Business Overview
- 11.17.5 ChoRe Latest Developments
- 11.18 AVVIE
- 11.18.1 AVVIE Company Information
- 11.18.2 AVVIE Mitral Regurgitation Product Offered
- 11.18.3 AVVIE Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 AVVIE Main Business Overview
- 11.18.5 AVVIE Latest Developments
- 11.19 Cardiovalve
- 11.19.1 Cardiovalve Company Information
- 11.19.2 Cardiovalve Mitral Regurgitation Product Offered
- 11.19.3 Cardiovalve Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.19.4 Cardiovalve Main Business Overview
- 11.19.5 Cardiovalve Latest Developments
- 11.20 HighLife SAS
- 11.20.1 HighLife SAS Company Information
- 11.20.2 HighLife SAS Mitral Regurgitation Product Offered
- 11.20.3 HighLife SAS Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.20.4 HighLife SAS Main Business Overview
- 11.20.5 HighLife SAS Latest Developments
- 11.21 Neovasc
- 11.21.1 Neovasc Company Information
- 11.21.2 Neovasc Mitral Regurgitation Product Offered
- 11.21.3 Neovasc Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.21.4 Neovasc Main Business Overview
- 11.21.5 Neovasc Latest Developments
- 11.22 MitrAssist Lifesciences
- 11.22.1 MitrAssist Lifesciences Company Information
- 11.22.2 MitrAssist Lifesciences Mitral Regurgitation Product Offered
- 11.22.3 MitrAssist Lifesciences Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.22.4 MitrAssist Lifesciences Main Business Overview
- 11.22.5 MitrAssist Lifesciences Latest Developments
- 11.23 Shanghai NewMed Medical
- 11.23.1 Shanghai NewMed Medical Company Information
- 11.23.2 Shanghai NewMed Medical Mitral Regurgitation Product Offered
- 11.23.3 Shanghai NewMed Medical Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.23.4 Shanghai NewMed Medical Main Business Overview
- 11.23.5 Shanghai NewMed Medical Latest Developments
- 11.24 Peijia Medical
- 11.24.1 Peijia Medical Company Information
- 11.24.2 Peijia Medical Mitral Regurgitation Product Offered
- 11.24.3 Peijia Medical Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.24.4 Peijia Medical Main Business Overview
- 11.24.5 Peijia Medical Latest Developments
- 11.25 MicroPort CardioFlow Medtech
- 11.25.1 MicroPort CardioFlow Medtech Company Information
- 11.25.2 MicroPort CardioFlow Medtech Mitral Regurgitation Product Offered
- 11.25.3 MicroPort CardioFlow Medtech Mitral Regurgitation Revenue, Gross Margin and Market Share (2020-2022)
- 11.25.4 MicroPort CardioFlow Medtech Main Business Overview
- 11.25.5 MicroPort CardioFlow Medtech Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Mitral Regurgitation. Industry analysis & Market Report on Mitral Regurgitation is a syndicated market report, published as Global Mitral Regurgitation Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Mitral Regurgitation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
